King's College London joins iManageCancer

iManageCancer welcomes a new official partner to the consortium: Kings College London (KCL).

This appointment follows months of planning to secure a third clinical pilot site for the project.

The Division of Cancer Studies at King's College London is part of one of the leading cancer research centres in Europe, the King's Health Partners' Integrated Cancer Centre.

Not only will KCL act as the new pilot site evaluating the entire platform with adult cancer patients in collaboration with the European Institute of Oncology in Milan, Italy, they will also contribute data for a new neutropenia prediction model being developed with Philips.

This new addition will strengthen the project and deliver a suite of clinically effective apps for people affected by cancer.